Investor Presentation Q1-Q3 2020

116 Investor presentation First nine months of 2020 Stable ownership structure - secured through A and B-share structure Share structure The Novo Nordisk Foundation Novo Nordisk Foundation Novo Holdings A/S Institutional and private investors • The Novo Nordisk Foundation is a self-governing institution that provides a stable basis for Novo Nordisk and • supports scientific, humanitarian and social purposes 76.6% of votes 28.3% of capital A shares 537m shares Novo Nordisk A/S 23.4% of votes 71.7% of capital • All strategic and operational matters are governed by the board and management of Novo Nordisk B shares 1,813m shares • Overlapping board memberships ensure that the Novo Nordisk Foundation and Novo Nordisk share vision and strategy Note: As of 11 May 2020. Treasury shares are included, however voting rights of treasury shares cannot be exercised Novo NordiskⓇ

View entire presentation